Position in INSM
as of Jun 30, 2026
· filed Aug 19, 2026
Position Value
$228,913
-$112,680 QoQ
Shares Held
2,147
+2.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#474
of 666 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Kingsview Wealth Management, LLC holds $4,094,329 across 12 Biotechnology names. INSM ranks #8 (5.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VKTX |
Viking Therapeutics, Inc.
|
25,674 | $1,001,542 | |
| 2 | IMRX |
Immuneering Corp
|
123,000 | $613,770 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
2,120 | $518,912 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
675 | $420,889 | |
| 5 | RPRX |
Royalty Pharma plc
|
6,377 | $357,558 | |
| 6 | TRVI |
Trevi Therapeutics, Inc.
|
15,895 | $296,441 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
464 | $230,482 | |
| 8 | INSM |
INSMED Inc
This page
|
2,147 | $228,913 |
All Filings in INSM
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $228,913 | 2,147 | Shares | Sole | 2026-08-19 | |
| 2026-03-31 | $341,593 | 2,089 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $360,436 | 2,071 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $334,247 | 2,321 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $227,547 | 2,261 | Shares | Sole | 2025-08-08 | |
| No filing history on record for this holder in this stock. | ||||||